This study delves into the behavioral complexities of autism spectrum disorder (ASD) by introducing the rigid-autonomous phase sequence (RAPS) formation concept.
Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL
Lisocabtagene maraleucel (liso-cel), a CAR T-cell therapy, is a cost effective second line treatment for relapsed and refractory (hard to treat) diffuse large B-cell lymphoma